Table 2.
Ref. | No. of LTA | No. of SLKT | Graft survival (LTA vs SLKT) | Patient survival (LTA vs SLKT) | Renal dysfunction post 1, 5 and 10 yr (LTA vs SLKT) | RRT post-transplantation (LTA vs SLKT) | Additional comments |
Jeyarajah et al[81] | 2442 (Cr > 2.0, nationawide) | 29 (single center) + 414 (nationwide) | N/A | 5 yr survival nationwide (50.4% vs 62.2%) | N/A | N/A | Interestingly, single center study had increased better survival in LTA than SLKT group |
Campbell et al[80] | 53 | 13 | N/A | N/A | 1 yr (1.4 mg/dL vs 1.5 mg/dL) | 2% vs 0% (at 12 mo) | Adjusting for baseline characteristics, SLKT patients had lower Cr than LTA at 12 mo (P = 0.01) |
Ruiz et al[83] | 80 (all with HRS) | 98 (22 with HRS and 76 with primary renal disease) | 1 yr SLKT survival (liver: 76% and kidney: 76%) | 1 yr survival (66% LTA vs 72% SLKT) | N/A | Post-op dialysis: (89% LTA pts for median of 9 d vs 55% SLKT pts for median 2.5 d) | 1 yr acute kidney rejection in CLKT was 14% vs 23% in 5 yr LT cohort |
Locke et al[84] | 19137 | 1032 | N/A | 1 yr survival for pts with ≥ 3 mo RRT: (70.8% LTA vs 84.5% SLKT) | N/A | N/A | Even after matched-control analysis, there was no benefit in SLKT cohort vs LTA cohort outside of aforementioned RRT |
Mehrabi et al[85] (literature review) | N/A | 3536 | Cumulative 5 yr SLKT survival of both organs (60.9%) | Cumulative 5 yr survival 42.6% | N/A | N/A | It is concluded that there is no definitive evidence of better graft/patient survival in SKLT vs LTA |
Chava et al[114] | N/A | 39 | 5 yr SLKT survival (liver: 73.7% and kidney: 70%) | 73.7% SLKT patient survival at 5 yr | N/A | N/A | 15 surviving patients (53.6%) had mild/moderate kidney dysfunction |
Fong et al[82] | 2774 | 1501 | 5 yr survival (58.9% LTA vs 65.3%, SLKT, P < 0.001) | 5 yr survival (62.9% LTA vs 67.4% SLKT, P < 0.001) | 0% with severe renal dysfunction | N/A | Liver graft survival and patient survival was better in SLKT vs LTA group |
Martin et al[88] 2012 | 66026 | 2327 | 15% decreased risk of graft loss with SLKT vs LTA (P = 0.02) | N/A | N/A | N/A | SLKT had higher graft survival rates than both KALT and LAKT |
Sharma et al[86] | 2112 (received RRT within 90 d before LT) | N/A | N/A | 78% LTA survival at 6 mo (not associated with RRT duration) | N/A | 8.90% | Risk for non-recovery increased by 3.6%/day of pre-LT RRT |
Catalano et al[89] | 74 | 37 | 10 yr survival (77% LTA vs 80% SLKT, P = 0.85) | 10 yr survival (79% LTA vs 86% SLKT, P = 0.56) | N/A | N/A | Acute rejection episodes involving the liver were less in SLKT vs LTA |
LTA: Liver transplantation alone; SLKT: Simultaneous liver kidney transplantationl; RRT: Renal replacement therapy; HRS: Hepatorenal syndrome; KALT: Kidney after liver transplantation; LAKT: Liver after kidney transplantation; N/A: Not available.